Protokol
5:2 i izmjenični post
Ovi protokoli daju najveći gubitak težine među svim protokolima posta, iz najmanje iznenađujućeg razloga: stvaraju najveći deficit.
Što protokoli zapravo uključuju
| Protokol | Dani posta | Unos tim danima | Ostali dani |
|---|---|---|---|
| 5:2 | Dva neuzastopna dana tjedno | Približno četvrtina normalnog unosa | Neograničeno |
| Post na svaki drugi dan (modificirani) | Svaki drugi dan | Približno četvrtina normalnog unosa | Neograničeno |
| Post na svaki drugi dan (pravi) | Svaki drugi dan | Ništa | Neograničeno |
Gotovo sva istraživanja koriste modificirane verzije. Pravi post s nultim unosom kalorija na svaki drugi dan rijedak je u istraživanjima jer pridržavanje protokola naglo pada.
Usporedni dokazi
Najkorisnija izravna analiza uspoređivala je post na svaki drugi dan, protokol 5:2 i vremenski ograničenu prehranu izravno kroz istraživanja [2]. Post na svaki drugi dan pokazao se boljim. Sustavni pregled strategija posta objavljen u BMJ-u u velikoj je mjeri sukladan tim rezultatima [1].
Jedan istinski utješan nalaz: metaanaliza ishoda vezanih za apetit pokazala je da povremeni post ne uzrokuje kompenzacijski nagli porast gladi koji su kritičari predviđali [3]. Ljudi ne nadoknađuju deficit hranom pouzdano tijekom dana bez posta.
Učinkovitost u smanjenju tjelesne težine
Gdje dokazi prestaju
Cochrane je istražio povremeni post za prevenciju kardiovaskularnih bolesti i zaključio da su dokazi nedovoljni [5] — ne negativni, nedovoljni. To je drugačija i iskrenija procjena od one koju obično iznose i entuzijasti i kritičari. Raniji sustavni pregled posta i gubitka težine došao je do sličnih zaključaka o kvaliteti istraživanja [6].
Rezultat vezan za jetru
Jedan od zanimljivijih pozitivnih nalaza: post na svaki drugi dan u kombinaciji s aerobnim vježbanjem poboljšao je nealkoholnu masnu bolest jetre u randomiziranom istraživanju, a kombinacija je nadmašila svaku komponentu zasebno [7]. Kao i kod vremenski ograničene prehrane, post uz vježbanje nadmašuje sam post.
Odabir između njih
- Birajte prema održivosti, a ne veličini učinka. Najveći učinak u istraživanju je bezvrijedan ako odustanete u šestom tjednu. Stope odustajanja u istraživanjima najmanje su čitan podatak u ovoj literaturi.
- Protokol 5:2 obično je kompromisno rješenje. Dva teška dana tjedno podnošljivija su za više ljudi nego svaki drugi dan.
- Danima posta potrebne su bjelančevine. Četvrtina normalnog unosa koja se sastoji od bjelančevina i povrća posve je drugačiji dan od četvrtine koja se sastoji od tosta.
- Ne kombinirajte protokole. Kombinacija posta na svaki drugi dan sa suženim prozorom prehrane danima bez posta nije testirana i uglavnom stvara vrlo velik deficit uz vrlo lošu pridržanost.
Često postavljana pitanja
Je li protokol 5:2 bolji od 16:8?
Mogu li vježbati na dan posta?
Pomaže li kod masne jetre?
Moraju li dva dana posta biti uzastopna?
References
Every citation below links to the original peer-reviewed record on PubMed or via DOI. Nothing here is a substitute for medical advice.
-
Intermittent fasting for adults with overweight or obesity Garegnani LI, Oltra G, Ivaldi D, et al. · The Cochrane database of systematic reviews · 2026 · Meta-analysis DOIPubMed 41692034Full text
-
Comparison of Different Intermittent Fasting Patterns or Different Extents of Calorie Restriction for Weight Loss and Metabolic Improvement in Adults: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials Wu X, Ding Y, Cao Q, et al. · Nutrition reviews · 2026 · Meta-analysis DOIPubMed 40367516
-
Meta-analysis and meta-regression of intermittent fasting effects on glycaemic control in type 2 diabetes: Subgroup analyses and variability Anasanti MD, Hamzah N · Diabetes & metabolic syndrome · 2025 · Meta-analysis DOIPubMed 40849220
-
The effects of intermittent fasting on sleep quality and cardiometabolic health outcomes in adults with overweight/obesity status: a systematic review and meta-analysis of randomized controlled trials Yong YN, McCubbin AJ, O'Driscoll DM, et al. · Sleep medicine reviews · 2025 · Meta-analysis DOIPubMed 41202521
-
Intermittent fasting for weight management and metabolic health: An updated comprehensive umbrella review of health outcomes Hua Z, Yang S, Li J, et al. · Diabetes, obesity & metabolism · 2025 · Systematic review DOIPubMed 39618023
-
Intermittent fasting strategies and their effects on body weight and other cardiometabolic risk factors: systematic review and network meta-analysis of randomised clinical trials Semnani-Azad Z, Khan TA, Chiavaroli L, et al. · BMJ (Clinical research ed.) · 2025 · Meta-analysis DOIPubMed 40533200Full text
-
A meta-analysis comparing the effectiveness of alternate day fasting, the 5:2 diet, and time-restricted eating for weight loss Elortegui Pascual P, Rolands MR, Eldridge AL, et al. · Obesity (Silver Spring, Md.) · 2023 · Meta-analysis DOIPubMed 36349432Full text
-
The Effect of Intermittent Fasting on Appetite: A Systematic Review and Meta-Analysis Elsworth RL, Monge A, Perry R, et al. · Nutrients · 2023 · Meta-analysis DOIPubMed 37299567Full text
-
Intermittent Fasting and Obesity-Related Health Outcomes: An Umbrella Review of Meta-analyses of Randomized Clinical Trials Patikorn C, Roubal K, Veettil SK, et al. · JAMA network open · 2021 · Systematic review DOIPubMed 34919135Full text
-
Intermittent fasting for the prevention of cardiovascular disease Allaf M, Elghazaly H, Mohamed OG, et al. · The Cochrane database of systematic reviews · 2021 · Systematic review DOIPubMed 33512717Full text
-
Intermittent fasting and weight loss: Systematic review Welton S, Minty R, O'Driscoll T, et al. · Canadian family physician Medecin de famille canadien · 2020 · Systematic review PubMed 32060194Full text
-
Three-week Alternate-day Fasting Improves Myocardial Flow Reserve and Reduces Oxygen Use in Overweight Individuals Kjærulff MLG, Luong TV, Munk OL, et al. · The Journal of clinical endocrinology and metabolism · 2026 · Randomised controlled trial DOIPubMed 40890042
-
Comparison of acute intermittent fasting interventions on mood, hunger, sleep quality, and diet satisfaction in females: A crossover experimental design Amendola K, Harris L, Ohayon R, et al. · PloS one · 2026 · Randomised controlled trial DOIPubMed 42647528Full text
-
Alternate-day fasting elicits larger changes in fat mass than time-restricted eating in adults without obesity - A randomized clinical trial Derron N, Güntner AT, Weber IC, et al. · Clinical nutrition (Edinburgh, Scotland) · 2025 · Randomised controlled trial DOIPubMed 40945487
-
Effect of a ketogenic diet, time-restricted eating, or alternate-day fasting on weight loss in adults with obesity: a randomized clinical trial Martínez-Montoro JI, Bandera B, Gutiérrez-Bedmar M, et al. · BMC medicine · 2025 · Randomised controlled trial DOIPubMed 40598397Full text
-
Effect of alternate day fasting combined with aerobic exercise on non-alcoholic fatty liver disease: A randomized controlled trial Ezpeleta M, Gabel K, Cienfuegos S, et al. · Cell metabolism · 2023 · Randomised controlled trial DOIPubMed 36549296Full text
-
Sustained alternate-day fasting potentiates doxorubicin cardiotoxicity Ozcan M, Guo Z, Valenzuela Ripoll C, et al. · Cell metabolism · 2023 · Randomised controlled trial DOIPubMed 36868222Full text
-
Intermittent Fasting in Weight Loss and Cardiometabolic Risk Reduction: A Randomized Controlled Trial Chair SY, Cai H, Cao X, et al. · The journal of nursing research : JNR · 2022 · Randomised controlled trial DOIPubMed 35050952
-
Alternate Day Fasting Improves Physiological and Molecular Markers of Aging in Healthy, Non-obese Humans Stekovic S, Hofer SJ, Tripolt N, et al. · Cell metabolism · 2019 · Randomised controlled trial DOIPubMed 31471173
-
Determinants of weight loss success with alternate day fasting Varady KA, Hoddy KK, Kroeger CM, et al. · Obesity research & clinical practice · 2016 · Randomised controlled trial DOIPubMed 26385599
-
[Intermittent fasting and human metabolic health] Carvajal V, Marín A, Gihardo D, et al. · Revista medica de Chile · 2023 · Review DOIPubMed 37906749
-
Intermittent Fasting and Metabolic Health Vasim I, Majeed CN, DeBoer MD · Nutrients · 2022 · Review DOIPubMed 35276989Full text